EarningsNxt
CalendarInsightsFor AgentsAbout
EarningsNxt

Earnings briefings in plain English, before and after the bell. Free calendar, Pro briefs at $8/mo.

Get briefs in your inbox For agents

Popular tickers

AAPLMSFTGOOGLAMZNNVDAMETATSLAJPMVUNHJNJWMT

Product

  • Earnings Calendar
  • Pricing
  • For Agents

Resources

  • Insights
  • API Reference
  • FAQ
  • llms.txt

Company

  • About
  • Contact
  • X / Twitter
  • StockTwits
  • Instagram

© 2026 EarningsNxt. For informational purposes only. Not financial advice. AI-assisted content may contain errors.

Terms of ServicePrivacy PolicyDisclaimerDisclosureAccessibilityDo Not Sell My Info
  1. Home
  2. BMRN

Equity Profile

BMRN

BioMarin Pharmaceutical Inc.

Health CareBiotechnology$10.6B market cap

Earnings scorecard

Last 76Q

EPS beat streak

1Q

EPS beat rate

63%

Avg EPS surprise

+556.49%

Avg 1-day reaction

-0.12%

Earnings history

77 quarters
Full history
QuarterReportedEst.ActualSurprise1-day
Q3-2026UpcomingOct 26, 2026————Preview
Q2-2026Aug 6, 2026$0.95$1.20+52.28%+2.59%Preview
Q1-2026May 4, 2026$0.97$0.76-2.44%+2.59%Preview
Q4-2025Feb 23, 2026$0.07$0.46+607.69%-1.81%Preview
Q3-2025Oct 27, 2025$0.80$0.12-84.98%-3.32%Preview
Q2-2025Aug 4, 2025ProPreview
Q1-2025May 1, 2025ProPreview
Q4-2024Feb 19, 2025ProPreview
Q3-2024Oct 29, 2024ProPreview
Q2-2024Aug 5, 2024ProPreview
Q1-2024Apr 24, 2024ProPreview
Q4-2023Feb 22, 2024ProPreview
Q3-2023Nov 1, 2023ProPreview
Q2-2023Jul 31, 2023ProPreview
Q1-2023Apr 26, 2023ProPreview
Q4-2022Feb 27, 2023ProPreview
Q3-2022Oct 26, 2022ProPreview
Q2-2022Aug 3, 2022ProPreview
Q1-2022Apr 27, 2022ProPreview
Q4-2021Feb 23, 2022ProPreview
Q3-2021Oct 27, 2021ProPreview
Q2-2021Jul 28, 2021ProPreview
Q1-2021Apr 29, 2021ProPreview
Q4-2020Feb 25, 2021ProPreview
Q3-2020Nov 5, 2020ProPreview
Q2-2020Aug 4, 2020ProPreview
Q1-2020Apr 29, 2020ProPreview
Q4-2019Feb 26, 2020ProPreview
Q3-2019Oct 23, 2019ProPreview
Q2-2019Aug 1, 2019ProPreview
Q1-2019Apr 25, 2019ProPreview
Q4-2018Feb 21, 2019ProPreview
Q3-2018Oct 25, 2018ProPreview
Q2-2018Aug 2, 2018ProPreview
Q1-2018Apr 25, 2018ProPreview
Q4-2017Feb 22, 2018ProPreview
Q3-2017Oct 26, 2017ProPreview
Q2-2017Aug 2, 2017ProPreview
Q1-2017May 4, 2017ProPreview
Q4-2016Feb 23, 2017ProPreview
Q3-2016Oct 27, 2016ProPreview
Q2-2016Aug 4, 2016ProPreview
Q1-2016Apr 28, 2016ProPreview
Q4-2015Feb 25, 2016ProPreview
Q3-2015Oct 29, 2015ProPreview
Q2-2015Aug 3, 2015ProPreview
Q1-2015Apr 30, 2015ProPreview
Q4-2014Feb 25, 2015ProPreview
Q3-2014Oct 23, 2014ProPreview
Q2-2014Jul 30, 2014ProPreview
Q1-2014May 1, 2014ProPreview
Q4-2013Feb 26, 2014ProPreview
Q3-2013Oct 24, 2013ProPreview
Q2-2013Jul 25, 2013ProPreview
Q1-2013Apr 25, 2013ProPreview
Q4-2012Feb 21, 2013ProPreview
Q3-2012Oct 25, 2012ProPreview
Q2-2012Aug 1, 2012ProPreview
Q1-2012Apr 26, 2012ProPreview
Q4-2011Feb 16, 2012ProPreview
Q3-2011Oct 27, 2011ProPreview
Q2-2011Jul 28, 2011ProPreview
Q1-2011Apr 28, 2011ProPreview
Q4-2010Feb 17, 2011ProPreview
Q3-2010Oct 28, 2010ProPreview
Q2-2010Aug 2, 2010ProPreview
Q1-2010Apr 29, 2010ProPreview
Q4-2009Feb 23, 2010ProPreview
Q3-2009Oct 28, 2009ProPreview
Q2-2009Jul 30, 2009ProPreview
Q1-2009Apr 30, 2009ProPreview
Q4-2008Feb 18, 2009ProPreview
Q3-2008Oct 28, 2008ProPreview
Q2-2008Aug 5, 2008ProPreview
Q1-2008Apr 29, 2008ProPreview
Q4-2007Feb 26, 2008ProPreview
Q3-2007Nov 1, 2007ProPreview

Next report

Q3-2026

Mon, Oct 26

After the close

Est. EPS

—

Est. Rev

—

Read the preview

About BMRN

Sector
Health Care
Industry
Biotechnology
Market cap
$10.6B

72 earlier quarters of EPS results and stock reactions are part of Pro.

No charge today · $8/mo after 7 days · Cancel anytime

Q2-2025Aug 4, 2025ProPreview
Q1-2025May 1, 2025ProPreview
Q4-2024Feb 19, 2025Pro
Preview
Q3-2024Oct 29, 2024ProPreview
Q2-2024Aug 5, 2024ProPreview
Q1-2024Apr 24, 2024ProPreview
Q4-2023Feb 22, 2024ProPreview
Q3-2023Nov 1, 2023ProPreview
Q2-2023Jul 31, 2023ProPreview
Q1-2023Apr 26, 2023ProPreview
Q4-2022Feb 27, 2023ProPreview
Q3-2022Oct 26, 2022ProPreview
Q2-2022Aug 3, 2022ProPreview
Q1-2022Apr 27, 2022ProPreview
Q4-2021Feb 23, 2022ProPreview
Q3-2021Oct 27, 2021ProPreview
Q2-2021Jul 28, 2021ProPreview
Q1-2021Apr 29, 2021ProPreview
Q4-2020Feb 25, 2021ProPreview
Q3-2020Nov 5, 2020ProPreview
Q2-2020Aug 4, 2020ProPreview
Q1-2020Apr 29, 2020ProPreview
Q4-2019Feb 26, 2020ProPreview
Q3-2019Oct 23, 2019ProPreview
Q2-2019Aug 1, 2019ProPreview
Q1-2019Apr 25, 2019ProPreview
Q4-2018Feb 21, 2019ProPreview
Q3-2018Oct 25, 2018ProPreview
Q2-2018Aug 2, 2018ProPreview
Q1-2018Apr 25, 2018ProPreview
Q4-2017Feb 22, 2018ProPreview
Q3-2017Oct 26, 2017ProPreview
Q2-2017Aug 2, 2017ProPreview
Q1-2017May 4, 2017ProPreview
Q4-2016Feb 23, 2017ProPreview
Q3-2016Oct 27, 2016ProPreview
Q2-2016Aug 4, 2016ProPreview
Q1-2016Apr 28, 2016ProPreview
Q4-2015Feb 25, 2016ProPreview
Q3-2015Oct 29, 2015ProPreview
Q2-2015Aug 3, 2015ProPreview
Q1-2015Apr 30, 2015ProPreview
Q4-2014Feb 25, 2015ProPreview
Q3-2014Oct 23, 2014ProPreview
Q2-2014Jul 30, 2014ProPreview
Q1-2014May 1, 2014ProPreview
Q4-2013Feb 26, 2014ProPreview
Q3-2013Oct 24, 2013ProPreview
Q2-2013Jul 25, 2013ProPreview
Q1-2013Apr 25, 2013ProPreview
Q4-2012Feb 21, 2013ProPreview
Q3-2012Oct 25, 2012ProPreview
Q2-2012Aug 1, 2012ProPreview
Q1-2012Apr 26, 2012ProPreview
Q4-2011Feb 16, 2012ProPreview
Q3-2011Oct 27, 2011ProPreview
Q2-2011Jul 28, 2011ProPreview
Q1-2011Apr 28, 2011ProPreview
Q4-2010Feb 17, 2011ProPreview
Q3-2010Oct 28, 2010ProPreview
Q2-2010Aug 2, 2010ProPreview
Q1-2010Apr 29, 2010ProPreview
Q4-2009Feb 23, 2010ProPreview
Q3-2009Oct 28, 2009ProPreview
Q2-2009Jul 30, 2009ProPreview
Q1-2009Apr 30, 2009ProPreview
Q4-2008Feb 18, 2009ProPreview
Q3-2008Oct 28, 2008ProPreview
Q2-2008Aug 5, 2008ProPreview
Q1-2008Apr 29, 2008ProPreview
Q4-2007Feb 26, 2008ProPreview
Q3-2007Nov 1, 2007ProPreview